FDA:  Shingrix Vaccine To Warn Of Association With Guillain-Barre Syndrome

(March 25, 2021, 1:02 PM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on March 24 required GlaxoSmithKline to add a warning to the label of the company’s Shingrix shingles vaccine to warn of an...
To view the full article, register now.